Haemonetics Corporation (HAE)

Working capital turnover

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Revenue (ttm)	US$ in thousands	1,360,824	1,373,515	1,361,223	1,333,895	1,309,055	1,270,181	1,239,232	1,218,534	1,168,660	1,129,246	1,083,714	1,026,126	993,196	953,223	933,825	903,414	870,463	883,926	902,525	945,605
Total current assets	US$ in thousands	934,975	1,005,870	955,902	978,578	768,903	764,982	865,744	801,607	769,722	706,309	715,789	687,783	756,031	729,455	699,246	684,368	693,546	668,348	760,279	759,410
Total current liabilities	US$ in thousands	578,113	253,233	273,946	260,076	300,383	261,755	264,215	236,939	251,816	226,889	262,175	180,487	442,266	355,411	288,470	228,339	253,495	194,384	338,568	407,827
Working capital turnover		3.81	1.82	2.00	1.86	2.79	2.52	2.06	2.16	2.26	2.36	2.39	2.02	3.17	2.55	2.27	1.98	1.98	1.86	2.14	2.69

March 31, 2025 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $1,360,824K ÷ ($934,975K – $578,113K)
= 3.81

Haemonetics Corporation's working capital turnover has fluctuated over the past few years, indicating varying efficiency in managing its working capital.

From March 31, 2024, to March 31, 2025, Haemonetics Corporation saw a significant improvement in its working capital turnover, reaching a high of 3.81. This implies that the company generated $3.81 in revenue for every dollar of working capital invested during that period, indicating strong efficiency in utilizing its current assets and liabilities.

However, this high was preceded by some fluctuations in the working capital turnover ratio. For example, from December 31, 2023, to June 30, 2024, there was a decrease in the ratio from 2.52 to 1.86, suggesting a potential inefficiency in managing working capital during that period.

Overall, Haemonetics Corporation has shown some variability in its working capital turnover, with periods of both strong and weaker efficiency in utilizing its working capital to generate revenue. Monitoring this metric closely can help the company streamline its operations and improve its overall financial performance.